Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche’s Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours:
70 Biggest Movers From Friday
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop
Toward the end of trading Friday, the Dow traded up 0.42% to 36,071.48 while the NASDAQ rose 0.84% to 15,835.89. The S&P also rose, gaining 0.61% to 4,677.60.
Why Did Oncorus Shares Slump To 52-Week Low Today?
Oncorus Inc (NASDAQ: ONCR) shares slumped after the company reported initial data for its investigational cancer therapy ONCR-177 from a Phase 1 trial in heavily pretreated patients with advanced, injectable solid tumors.
Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet
Midway through trading Friday, the Dow traded up 0.31% to 36,031.95 while the NASDAQ rose 0.54% to 15,788.64. The S&P also rose, gaining 0.43% to 4,669.15.
Mid-Morning Market Update: Markets Rise; AstraZeneca’s COVID-19 Vaccine Turns Profitable In Third Quarter
Following the market opening Friday, the Dow traded up 0.25% to 36,012.29 while the NASDAQ rose 0.24% to 15,741.23. The S&P also rose, gaining 0.14% to 4,655.99.